These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 36116530)
1. Annexin A2 (AnxA2) association with the clinicopathological data in different breast cancer subtypes: A possible role for AnxA2 in tumor heterogeneity and cancer progression. Abdelraouf EM; Hussein RRS; Shaaban AH; El-Sherief HAM; Embaby AS; Abd El-Aleem SA Life Sci; 2022 Nov; 308():120967. PubMed ID: 36116530 [TBL] [Abstract][Full Text] [Related]
2. Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis. Chaudhary P; Gibbs LD; Maji S; Lewis CM; Suzuki S; Vishwanatha JK Breast Cancer Res; 2020 Jan; 22(1):11. PubMed ID: 31992335 [TBL] [Abstract][Full Text] [Related]
3. Prognostic features of Annexin A2 expression in prostate cancer. Tan SH; Young D; Chen Y; Kuo HC; Srinivasan A; Dobi A; Petrovics G; Cullen J; Mcleod DG; Rosner IL; Srivastava S; Sesterhenn IA Pathology; 2021 Feb; 53(2):205-213. PubMed ID: 32967771 [TBL] [Abstract][Full Text] [Related]
4. Relationship Between Circulating Tumor Cells and Annexin A2 in Early Breast Cancer Patients. Bystricky B; Cierna Z; Sieberova G; Janega P; Karaba M; Minarik G; Benca J; Sedlackova T; Jurisova S; Gronesova P; Pindak D; Macuch J; Mardiak J; Mego M Anticancer Res; 2017 May; 37(5):2727-2734. PubMed ID: 28476852 [TBL] [Abstract][Full Text] [Related]
5. CCL18 promotes the invasion and metastasis of breast cancer through Annexin A2. Zhao C; Zheng S; Yan Z; Deng Z; Wang R; Zhang B Oncol Rep; 2020 Feb; 43(2):571-580. PubMed ID: 31894281 [TBL] [Abstract][Full Text] [Related]
6. High Co-expression of Large Tenascin C Splice Variants in Stromal Tissue and Annexin A2 in Cancer Cell Membranes is Associated with Poor Prognosis in Pancreatic Cancer. Hagiwara K; Harimoto N; Yokobori T; Muranushi R; Hoshino K; Gantumur D; Yamanaka T; Ishii N; Tsukagoshi M; Igarashi T; Tanaka H; Watanabe A; Kubo N; Araki K; Hosouchi Y; Shirabe K Ann Surg Oncol; 2020 Mar; 27(3):924-930. PubMed ID: 31463696 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer. Choi CH; Chung JY; Chung EJ; Sears JD; Lee JW; Bae DS; Hewitt SM BMC Cancer; 2016 Jul; 16():448. PubMed ID: 27402115 [TBL] [Abstract][Full Text] [Related]
8. Comparisons of p53, KI67 and BRCA1 expressions in patients with different molecular subtypes of breast cancer and their relationships with pathology and prognosis. Li Y; Zhang X; Qiu J; Pang T; Huang L; Zeng Q J BUON; 2019; 24(6):2361-2368. PubMed ID: 31983107 [TBL] [Abstract][Full Text] [Related]
9. Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells. Wang T; Yuan J; Zhang J; Tian R; Ji W; Zhou Y; Yang Y; Song W; Zhang F; Niu R Oncotarget; 2015 Oct; 6(31):30975-92. PubMed ID: 26307676 [TBL] [Abstract][Full Text] [Related]
10. Ki67 expression in breast cancer. Correlation with prognostic markers and clinicopathological parameters in Saudi patients. Elkablawy MA; Albasri AM; Mohammed RA; Hussainy AS; Nouh MM; Alhujaily AS Saudi Med J; 2016 Feb; 37(2):137-41. PubMed ID: 26837394 [TBL] [Abstract][Full Text] [Related]
11. Tyr23 phosphorylation of Anxa2 enhances STAT3 activation and promotes proliferation and invasion of breast cancer cells. Yuan J; Yang Y; Gao Z; Wang Z; Ji W; Song W; Zhang F; Niu R Breast Cancer Res Treat; 2017 Jul; 164(2):327-340. PubMed ID: 28470457 [TBL] [Abstract][Full Text] [Related]
12. Differential distribution of microRNAs in breast cancer grouped by clinicopathological subtypes. Li JY; Jia S; Zhang WH; Zhang Y; Kang Y; Li PS Asian Pac J Cancer Prev; 2013; 14(5):3197-203. PubMed ID: 23803104 [TBL] [Abstract][Full Text] [Related]
13. Expression and clinical significance of annexin A2 and human epididymis protein 4 in endometrial carcinoma. Deng L; Gao Y; Li X; Cai M; Wang H; Zhuang H; Tan M; Liu S; Hao Y; Lin B J Exp Clin Cancer Res; 2015 Sep; 34(1):96. PubMed ID: 26362938 [TBL] [Abstract][Full Text] [Related]
14. MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression. Kpetemey M; Dasgupta S; Rajendiran S; Das S; Gibbs LD; Shetty P; Gryczynski Z; Vishwanatha JK Mol Cancer; 2015 Aug; 14():156. PubMed ID: 26272794 [TBL] [Abstract][Full Text] [Related]
15. Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinoma. Zhang HJ; Yao DF; Yao M; Huang H; Wu W; Yan MJ; Yan XD; Chen J World J Gastroenterol; 2012 Nov; 18(41):5897-904. PubMed ID: 23139605 [TBL] [Abstract][Full Text] [Related]
16. ANXA2 expression in African American triple-negative breast cancer patients. Gibbs LD; Chaudhary P; Mansheim K; Hare RJ; Mantsch RA; Vishwanatha JK Breast Cancer Res Treat; 2019 Feb; 174(1):113-120. PubMed ID: 30478786 [TBL] [Abstract][Full Text] [Related]
17. Ki67 as Proliferative Marker in Patients with Early Breast Cancer and Its Association with Clinicopathological Factors. de Gregorio A; Friedl TWP; Hering E; Widschwendter P; de Gregorio N; Bekes I; Janni W; Dayan D; Huober JB Oncology; 2021; 99(12):780-789. PubMed ID: 34535596 [TBL] [Abstract][Full Text] [Related]
18. Targeted Nanocurcumin Therapy Using Annexin A2 Anitbody Improves Tumor Accumulation and Therapeutic Efficacy Against Highly Metastatic Breast Cancer. Mukerjee A; Ranjan AP; Vishwanatha JK J Biomed Nanotechnol; 2016 Jul; 12(7):1374-92. PubMed ID: 29336533 [TBL] [Abstract][Full Text] [Related]
19. [Expression of Ki67 and clinicopathological features in breast cancer]. Wang B; Wang X; Wang J; Xuan L; Wang Z; Wang X; Gao J; Zhang H Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):273-5. PubMed ID: 24989913 [TBL] [Abstract][Full Text] [Related]
20. Clinical Significance of Annexin A2 Expression in Breast Cancer Patients. Gibbs LD; Mansheim K; Maji S; Nandy R; Lewis CM; Vishwanatha JK; Chaudhary P Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33374917 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]